Breaking News

MilliporeSigma Acquires MAST Platform from Lonza

Automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany has acquired MAST (Modular Automated Sampling Technology) platform from Lonza. The MAST platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. Financial details were not disclosed.   The MAST platform enables the gathering of more frequent samples and collection of real-time data, including pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters